Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement.

Love SC, Novak I, Kentish M, Desloovere K, Heinen F, Molenaers G, O'Flaherty S, Graham HK; Cerebral Palsy Institute.

Eur J Neurol. 2010 Aug;17 Suppl 2:9-37. doi: 10.1111/j.1468-1331.2010.03126.x.

PMID:
20633177
2.

Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Lukban MB, Rosales RL, Dressler D.

J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. Review.

PMID:
19142573
3.

Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement.

Olver J, Esquenazi A, Fung VS, Singer BJ, Ward AB; Cerebral Palsy Institute.

Eur J Neurol. 2010 Aug;17 Suppl 2:57-73. doi: 10.1111/j.1468-1331.2010.03128.x.

PMID:
20633179
4.

Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.

Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.

Disabil Rehabil. 2013 Apr;35(7):596-605. doi: 10.3109/09638288.2012.711898. Epub 2012 Aug 28.

5.

Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement.

Fehlings D, Novak I, Berweck S, Hoare B, Stott NS, Russo RN; Cerebral Palsy Institute.

Eur J Neurol. 2010 Aug;17 Suppl 2:38-56. doi: 10.1111/j.1468-1331.2010.03127.x.

PMID:
20633178
6.

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003469. doi: 10.1002/14651858.CD003469.pub4. Review.

PMID:
20091546
7.

Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.

Ryll U, Bastiaenen C, De Bie R, Staal B.

Dev Med Child Neurol. 2011 Mar;53(3):210-6. doi: 10.1111/j.1469-8749.2010.03890.x. Review.

8.

Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Thorley M, Donaghey S, Edwards P, Copeland L, Kentish M, McLennan K, Lindsley J, Gascoigne-Pees L, Sakzewski L, Boyd RN.

BMC Pediatr. 2012 Aug 9;12:120. doi: 10.1186/1471-2431-12-120.

9.

Botulinum toxin consensus statement. Foreword.

Novak I, Graham HK.

Eur J Neurol. 2010 Aug;17 Suppl 2:iii-iv. doi: 10.1111/j.1468-1331.2010.03133.x. No abstract available.

PMID:
20633175
10.

Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.

Lorin K, Forsberg A.

Child Care Health Dev. 2016 Jul;42(4):494-503. doi: 10.1111/cch.12350. Epub 2016 May 19.

PMID:
27198886
11.
12.

Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy.

Camargo CH, Teive HA, Zonta M, Silva GC, Oliveira MR, Roriz MM, Brandi IV, Becker N, Scola RH, Werneck LC.

Arq Neuropsiquiatr. 2009 Mar;67(1):62-8.

13.

Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.

Koman LA, Paterson Smith B, Balkrishnan R.

Paediatr Drugs. 2003;5(1):11-23. Review.

PMID:
12513103
14.

Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.

Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, Boyd RN.

J Pediatr. 2014 Jul;165(1):140-146.e4. doi: 10.1016/j.jpeds.2014.01.050. Epub 2014 Mar 12.

PMID:
24630348
15.

Intensive therapy following upper limb botulinum toxin A injection in young children with unilateral cerebral palsy: a randomized trial.

Hoare B, Imms C, Villanueva E, Rawicki HB, Matyas T, Carey L.

Dev Med Child Neurol. 2013 Mar;55(3):238-47. doi: 10.1111/dmcn.12054. Epub 2012 Dec 12.

16.

Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.

Pin TW, Elmasry J, Lewis J.

Dev Med Child Neurol. 2013 Apr;55(4):304-13. doi: 10.1111/j.1469-8749.2012.04438.x. Epub 2012 Oct 24. Review.

17.

A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.

Chaléat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Bérard C, Bernard JC, Bourg V, Deleplanque B, Dulieu I, Evrard P, Filipetti P, Flurin V, Gallien P, Héron-Long B, Hodgkinson I, Husson I, Jaisson-Hot I, Maupas E, Meurin F, Monnier G, Pérennou D, Pialoux B, Quentin V, Moreau MS, Schneider M, Yelnik A, Marque P.

Eur J Paediatr Neurol. 2011 Sep;15(5):439-48. doi: 10.1016/j.ejpn.2010.04.006. Epub 2011 Jul 13.

PMID:
21745754
18.

High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.

Intiso D, Simone V, Di Rienzo F, Iarossi A, Pazienza L, Santamato A, Maruzzi G, Basciani M.

NeuroRehabilitation. 2014;34(3):515-22. doi: 10.3233/NRE-141052.

PMID:
24473245
19.
20.

A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.

Ferrari A, Maoret AR, Muzzini S, Alboresi S, Lombardi F, Sgandurra G, Paolicelli PB, Sicola E, Cioni G.

Res Dev Disabil. 2014 Oct;35(10):2505-13. doi: 10.1016/j.ridd.2014.06.001. Epub 2014 Jul 2.

PMID:
24995688

Supplemental Content

Support Center